[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371033-105":59,"doc-detail-371033-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ubiquitin-conjugating-enzyme-e2s-serves-as-a-prognostic-marker-for-skin-cutaneous-melanoma","Ubiquitin-conjugating enzyme E2S serves as a prognostic marker for skin cutaneous melanoma","","This study investigates how ubiquitin-conjugating enzyme E2S (UBE2S) functions as a prognostic marker in skin cutaneous melanoma (SKCM) and how it relates to the tumor microenvironment (TME), aiming to support precision oncology through identification of potential therapeutic directions. UBE2S expression was analyzed in normal skin and SKCM tissues using multiple public gene-expression and protein databases, and patient prognosis associations were evaluated across survival-oriented resources. Results show higher UBE2S mRNA and protein levels in tumors, membrane localization, and strong links to TME immune infiltration and cellular functional states.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ubiquitin-conjugating-enzyme-e2s-serves-as-a-prognostic-marker-for-skin-cutaneous-melanoma/371033/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ubiquitin-conjugating-enzyme-e2s-serves-as-a-prognostic-marker-for-skin-cutaneous-melanoma/371033.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study evaluate as a prognostic marker in skin cutaneous melanoma?","Question",{"text":112,"@type":113},"The study evaluates ubiquitin-conjugating enzyme E2S (UBE2S) expression as a prognostic marker in skin cutaneous melanoma (SKCM). It also examines how UBE2S relates to the tumor microenvironment (TME).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases and resources were used to assess UBE2S expression and prognosis?",{"text":117,"@type":113},"UBE2S expression and prognostic associations were assessed using Sangerbox, GEPIA2, DiSignAtlas, Ualcan, TISIDB, the Human Protein Atlas (HPA), and CellTracer, along with CancerSEA for single-cell related roles.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings regarding UBE2S levels in tumor versus normal tissue?",{"text":121,"@type":113},"Across multiple databases, UBE2S mRNA and protein levels were significantly higher in cancer tissues than in normal tissues. UBE2S was mainly localized to the cell membrane and correlated with poor patient prognosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371033,1790225908,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Ubiquitin-conjugating enzyme E2S serves as a prognostic marker for skin cutaneous melanoma  \nGuojun Du1\\#^, Lei Li1\\#, Yunhui Jiang2, Peipei Yang3, Ganglin Xu3  \n1Emergency Department, Jingmen People’s Hospital, Jingchu University of Technology Affiliated Jingmen People’s Hospital, Jingmen, China; 2Department of Pathology, Jingmen People’s Hospital & Jingchu University of Technology Affiliated Jingmen People’s Hospital, Jingmen, China; 3Department of Dermatology, Jingmen People’s Hospital & Jingchu University of Technology Affiliated Jingmen People’s Hospital, Jingmen, China Contributions: (I) Conception and design: P Yang, G Xu; (II) Administrative support: P Yang, G Xu; (III) Provision of study materials: G Du, L Li;  \n(IV) Collection and assembly of data: G Du, L Li; (V) Data analysis and interpretation: Y Jiang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Peipei Yang, MM; Ganglin Xu, MM. Department of Dermatology, Jingmen People’s Hospital & Jingchu University of Technology Affiliated Jingmen People’s Hospital, No. 39 Xiangshan Road, Dongbao Zone, Jingmen 448000, China. Email: ppy1989@163.com; jmganglinxu@163.com.  \nBackground: This study investigates the expression of ubiquitin-conjugating enzyme E2S (UBE2S) as a significant prognostic marker for skin cutaneous melanoma (SKCM) and its association with the tumor microenvironment (TME) . The research aimed to advance precision oncology by identifying novel  \ntherapeutic targets for SKCM.  \nMethods: UBE2S expression in normal skin and SKCM tissues was analyzed using Sangerbox, Gene Expression Profiling Interactive Analysis 2 (GEPIA2), and DiSignAtlas databases. Its relationship with SKCM prognosis was examined through GEPIA2, Sangerbox, Ualcan, and TISIDB. The Human Protein Atlas (HPA) database assessed UBE2S protein expression and localization in cancerous and adjacent tissues, normal skin single-cell subgroups, and various cell lines. The CellTracer database explored UBE2S expression and cell differentiation in SKCM single-cell subgroups. CancerSEA and CellTracer databases were utilized to explore UBE2S’s role in SKCM single-cell analysis, while TISIDB examined its correlation  \nwith the TME.  \nResults: Data from various databases showed significantly higher UBE2S messenger RNA (mRNA) and protein levels in cancer tissues compared to normal tissues. UBE2S, mainly found on the cell membrane, is linked to poor patient prognosis (P\u003C0.05) . UBE2S was highly expressed in normal skin, SKCM immune cells, and non-immune cell subpopulations, with a strong correlation to immune-related indicators in the SKCM TME (P\u003C0.001) . The A-431 and SK-MEL-30 cell lines ranked 7th and 12th in UBE2S expression among all cell lines. UBE2S expression was also positively linked to proliferation, invasion, metastasis, cell  \ncycle, and quiescence (P\u003C0.05) .  \nConclusions: UBE2S has the potential to serve as a prognostic biomarker for SKCM, demonstrating a strong correlation with cellular infiltration within the SKCM TME and the functional status of individual  \ncells.  \nKeywords: Skin cutaneous melanoma (SKCM); ubiquitin-conjugating enzyme E2S (UBE2S); prognosis; tumor  \nmicroenvironment (TME); database  \nSubmitted Mar 19, 2025. Accepted for publication Aug 11, 2025. Published online Nov 26, 2025.  \ndoi: 10.21037/tcr-2025-620  \nView this article at: [https://dx.doi.org/10.21037/tcr-2025-620](https://dx.doi.org/10.21037/tcr-2025-620)  \n^ ORCID: 0009-0008-0494-3870.  \n© AME Publishing Company. Transl Cancer Res 2025;14(11):7536-7549 | [https://dx.doi.org/10.21037/tcr-2025-620](https://dx.doi.org/10.21037/tcr-2025-620)  \nTranslational Cancer Research, Vol 14, No 11 November 2025 7537  \nIntroduction  \nSkin cuta neo us melanoma (SKCM), a common malignant tumor originating from melanocytes, is characterized by rapidly proliferating cells that evade immune surveillance (1) . This evasion leads","cbCaiemSRCImXJiv","https://ap.wps.com/l/cbCaiemSRCImXJiv","pdf",7465478,14,"English","# Introduction\n# Methods\n# Results\n# Conclusions\n# Key findings","[{\"question\":\"What does the study evaluate as a prognostic marker in skin cutaneous melanoma?\",\"answer\":\"The study evaluates ubiquitin-conjugating enzyme E2S (UBE2S) expression as a prognostic marker in skin cutaneous melanoma (SKCM). It also examines how UBE2S relates to the tumor microenvironment (TME).\"},{\"question\":\"Which databases and resources were used to assess UBE2S expression and prognosis?\",\"answer\":\"UBE2S expression and prognostic associations were assessed using Sangerbox, GEPIA2, DiSignAtlas, Ualcan, TISIDB, the Human Protein Atlas (HPA), and CellTracer, along with CancerSEA for single-cell related roles.\"},{\"question\":\"What were the main findings regarding UBE2S levels in tumor versus normal tissue?\",\"answer\":\"Across multiple databases, UBE2S mRNA and protein levels were significantly higher in cancer tissues than in normal tissues. UBE2S was mainly localized to the cell membrane and correlated with poor patient prognosis.\"}]","Ubiquitin-conjugating enzyme E2S serves as a prognostic marker for skin cutaneous melanoma | PDF",1790191084,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/132feca8c4e5900b9b31e335d2144cde.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b768ee9f537d28dbdf96a77318ca2f6.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7deff2dc3e87f7851c50b0bb3e71bd51.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0317a2342326ad2d886be090e0e491bd.webp",980,1283]